CVE-2026-54495Cross-namespace FeatureFlagSource and InProcessConfiguration resolution exposes spec contents on multi-tenant clusters
Updated under an hour ago ()
Does this affect you?
It affects open-feature-operator. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
The OpenFeature Operator allows users to expose feature flags to applications. In version 0.9.2 and earlier, a tenant who can create a controller-owned workload can use the openfeature.dev/featureflagsource annotation with NAMESPACE/NAME syntax to reference a FeatureFlagSource or InProcessConfiguration in another namespace. On multi-tenant clusters that use namespaces as trust boundaries, the cluster-scoped operator reads that resource and materializes spec.envVars literal values, spec.httpSyncBearerToken, sync URIs, and supporting ConfigMaps into the tenant's workload. Single-tenant clusters are not impacted, secretKeyRef and configMapKeyRef values remain namespace-local, and creating a FeatureFlagSource is not required.
- CVSS
- 4.3 MEDIUM (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
- Weakness (CWE)
- CWE-668
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- GitHub_M
- NVD analysis
- Awaiting Analysis
- Record last updated
- Sep 18, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
open-feature open-feature-operator open_feature:operator (from the name) | through 0.9.2 | CNA record |
References
- https://github.com/open-feature/open-feature-operator/security/advisories/GHSA-398h-7f66-3h4px-refsource-confirm
- https://github.com/open-feature/open-feature-operator/issues/847x-refsource-misc
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.